Brief: Alterity Therapeutics HY Loss Attributable A$6.5 Million
28/02/2024 06:10
Feb 28 (Reuters) - Alterity Therapeutics Ltd ATH.AX :
* HY LOSS ATTRIBUTABLE A$6.5 MILLION VERSUS LOSS A$8.0
MILLION
* HY REVENUE FROM ORDINARY ACTIVITIES A$118,400, UP 940.5%
Source text for Eikon: ID:nASX3RdlTx
Further company coverage: ATH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital